D356-2722 Screening compound: 9-fluoro-6-{2-oxo-2-[3-oxo-3,4-dihydro-1(2H)-quinoxalinyl]ethyl}-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione

D356-2722 Screening compound: 9-fluoro-6-{2-oxo-2-[3-oxo-3,4-dihydro-1(2H)-quinoxalinyl]ethyl}-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione
D356-2722 Screening compound: 9-fluoro-6-{2-oxo-2-[3-oxo-3,4-dihydro-1(2H)-quinoxalinyl]ethyl}-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound D356-2722
9-fluoro-6-{2-oxo-2-[3-oxo-3,4-dihydro-1(2H)-quinoxalinyl]ethyl}-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D356-2722

Molecular Formula

C22H16FN3O4S (C22 H16 FN3 O4 S)

Compound Name

9-fluoro-6-{2-oxo-2-[3-oxo-3,4-dihydro-1(2H)-quinoxalinyl]ethyl}-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione

IUPAC name

13-fluoro-9-[2-oxo-2-(3-oxo-1234-tetrahydroquinoxalin-1-yl)ethyl]-8lambda6-thia-9-azatricyclo[8.4.0.0^{27}]tetradeca-1(14)2(7)351012-hexaene-88-dione

SMILES

O=C(CN(c(ccc(F)c1)c1-c1c2cccc1)S2(=O)=O)N(C1)c(cccc2)c2NC1=O

InChI

InChI=1S/C22H16FN3O4S/c23-14-9-10-18-16(11-14)15-5-1-4-8-20(15)31(29,30)26(18)13-22(28)25-12-21(27)24-17-6-2-3-7-19(17)25/h1-11H,12-13H2,(H,24,27)

InChI Key

IGIWKZPSOKQESM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14856341

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.714

Distribution Coefficient, logD

2.712

Water Solubility, LogSw

-3.54

Polar Surface Area

70.653

Acid Dissociation Constant (pKa)

9.91

Base Dissociation Constant (pKb)

-0.43

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

D356-2722 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with D356-2722 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D356-2722?
Check Price and Availability of D356-2722, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D356-2722 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D356-2722
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D356-2722
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D356-2722 available by request